Daewon Pharmaceutical Co., Ltd. (KRX:003220)

Daewon Pharmaceutical Revenue

Daewon Pharmaceutical had revenue of 158.06B KRW in the quarter ending March 31, 2026, with 0.14% growth. This brings the company's revenue in the last twelve months to 605.66B, up 1.31% year-over-year. In the year 2025, Daewon Pharmaceutical had annual revenue of 605.43B with 1.22% growth.

• Revenue (ttm): 605.66B
• Revenue Growth: +1.31%
• P/S Ratio: 0.37
• Revenue / Employee: 472.07M
• Employees: 1,283
• Market Cap: 225.91B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	605.43B	7.27B	1.22%
Dec 31, 2024	598.16B	71.21B	13.51%
Dec 31, 2023	526.95B	48.07B	10.04%
Dec 31, 2022	478.88B	124.71B	35.21%
Dec 31, 2021	354.18B	45.68B	14.81%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 7, 2026

Data Sources Report a data error